440 related articles for article (PubMed ID: 18701208)
21. An antineuronal autoantibody in paraneoplastic opsoclonus.
Budde-Steffen C; Anderson NE; Rosenblum MK; Graus F; Ford D; Synek BJ; Wray SH; Posner JB
Ann Neurol; 1988 May; 23(5):528-31. PubMed ID: 3389761
[TBL] [Abstract][Full Text] [Related]
22. Ophthalmoplegia associated with the anti-Ri antibody.
Ohmer R; Golnik KC; Richards AI; Kosmorsky GS
J Neuroophthalmol; 1999 Dec; 19(4):246-8. PubMed ID: 10608678
[TBL] [Abstract][Full Text] [Related]
23. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
[TBL] [Abstract][Full Text] [Related]
24. Paraneoplastic cerebellar degeneration associated with an onconeural antibody against creatine kinase, brain-type.
Tetsuka S; Tominaga K; Ohta E; Kuroiwa K; Sakashita E; Kasashima K; Hamamoto T; Namekawa M; Morita M; Natsui S; Morita T; Tanaka K; Takiyama Y; Nakano I; Endo H
J Neurol Sci; 2013 Dec; 335(1-2):48-57. PubMed ID: 24018129
[TBL] [Abstract][Full Text] [Related]
25. Anti-Ri-associated paraneoplastic cerebellar and brainstem degenerative syndrome.
Tay JK; Miller J; Joshi A; Athey RJ
J R Coll Physicians Edinb; 2012; 42(3):221-4. PubMed ID: 22953316
[TBL] [Abstract][Full Text] [Related]
26. [Anti-Ri paraneoplastic syndrome associated with ophtalmoplegia, blepharospasm and palilalia].
Martinaud O; Guegan-Massardier E; Iasci L; Miret N; Mihout B; Hannequin D
Rev Neurol (Paris); 2005 Jan; 161(1):81-6. PubMed ID: 15678006
[TBL] [Abstract][Full Text] [Related]
27. CD8 positive T-cell infiltration in the dentate nucleus of paraneoplastic cerebellar degeneration.
Aye MM; Kasai T; Tashiro Y; Xing HQ; Shirahama H; Mitsuda M; Suetsugu T; Tanaka K; Osame M; Izumo S
J Neuroimmunol; 2009 Mar; 208(1-2):136-40. PubMed ID: 19217169
[TBL] [Abstract][Full Text] [Related]
28. Paraneoplastic neurological syndrome: patient with anti-Yo antibody and breast cancer: a case report.
Dorn C; Knobloch C; Kupka M; Morakkabati-Spitz N; Schmolling J
Arch Gynecol Obstet; 2003 Nov; 269(1):62-5. PubMed ID: 14605824
[TBL] [Abstract][Full Text] [Related]
29. [Paraneoplastic limbic encephalitis with positive anti-RI antibodies and mediastinal seminoma].
Launay M; Bozzolo E; Venissac N; Delmont E; Fredenrich A; Thomas P
Rev Neurol (Paris); 2008; 164(6-7):612-9. PubMed ID: 18565362
[TBL] [Abstract][Full Text] [Related]
30. Paraneoplastic cerebellar degeneration in a patient with pseudomyxoma peritonei and breast cancer: case report and literature review.
Ardavanis A; Sykoutri D; Kountourakis P; Doufexis D; Korkolis D; Tzerbini H; Skarlatos I; Mosa E; Rigatos G
In Vivo; 2009; 23(5):835-8. PubMed ID: 19779120
[TBL] [Abstract][Full Text] [Related]
31. [Multiple paraneoplastic syndromes occurring in the same patient: clinical, imaging and neuro-pathological documentation].
Sá G; Correia C; Pires M; Lopes G
Acta Med Port; 2006; 19(6):489-93. PubMed ID: 17583609
[TBL] [Abstract][Full Text] [Related]
32. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
33. Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome.
Aboul-Enein F; Höftberger R; Buxhofer-Ausch V; Drlicek M; Lassmann H; Budka H; Kristoferitsch W
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):248-52. PubMed ID: 17995920
[No Abstract] [Full Text] [Related]
34. [Paraneoplastic cerebellar degeneration with bladder cancer confirmed the existence of an anti-neural antibody: a case report].
Kawanishi K; Morita M; Nakahara K; Tetsuka S; Kouki T; Tominaga K; Endo H; Yashiro T; Tanaka K; Nakano I
Brain Nerve; 2013 Nov; 65(11):1401-5. PubMed ID: 24200618
[TBL] [Abstract][Full Text] [Related]
35. Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.
Rojas-Marcos I; Picard G; Chinchón D; Gelpi E; Psimaras D; Giometto B; Delattre JY; Honnorat J; Graus F
Neuro Oncol; 2012 Apr; 14(4):506-10. PubMed ID: 22351748
[TBL] [Abstract][Full Text] [Related]
36. Isolated ZIC4 antibodies in paraneoplastic cerebellar syndrome with an underlying ovarian tumor.
Kerasnoudis A; Rockhoff M; Federlein J; Gold R; Krogias C
Arch Neurol; 2011 Aug; 68(8):1073. PubMed ID: 21825246
[TBL] [Abstract][Full Text] [Related]
37. [Paraneoplastic cerebellar degeneration associated with anti-Ma2 antibodies].
Ameneiros-Lago E; Fernández-Fernández FJ; Lijó-Carballeda C
Med Clin (Barc); 2016 Nov; 147(10):e55-e56. PubMed ID: 27650210
[No Abstract] [Full Text] [Related]
38. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
Holzmann P; Holy D; Stillhard G; Janda M; Möbr P
Schweiz Med Wochenschr; 1998 Jun; 128(23):906-8. PubMed ID: 9658519
[TBL] [Abstract][Full Text] [Related]
39. Ovarian cancer and late onset paraneoplastic cerebellar degeneration.
Goldstein BH; Birk CL; Van Houten M; Veve R; Brown JV; Rettenmaier MA; Micha JP
Arch Gynecol Obstet; 2009 Jul; 280(1):99-101. PubMed ID: 18987868
[TBL] [Abstract][Full Text] [Related]
40. Immunological Bases of Paraneoplastic Cerebellar Degeneration and Therapeutic Implications.
Yshii L; Bost C; Liblau R
Front Immunol; 2020; 11():991. PubMed ID: 32655545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
